ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0998

Trends and Disparities in Cardiovascular Deaths in Systemic Lupus Erythematosus: A Population-Based Retrospective Study in the United States from 1999 to 2021

Faizan Ahmed1, Shreyas Patil2, Yash Deshpande3, Simran Bhimani3, Anand Maligireddy4, Leighton Hope5, Tehmasp Rehman Mirza6, Mohamed Abugrin7, Hardik Valand8, Chaitanya Rojulpote5 and karthik Gonuguntla9, 1Ameer-ud-Din Medical College, Lahore, Pakistan, 2The Wright Center, Scranton, 3The Wright Center for Graduate Medical Education, Scranton, PA, 4The Wright Center, GME, Scranton, PA, 5Saint Louis University, St. Louis, MO, 6Department of Internal Medicine, Shalamar Medical and Dental College, Lahore, 7Bassett Medical Center, Cooperstown, 8Trinity Health System, Steubenville, OH, 9West Virginia University, Morgantown

Meeting: ACR Convergence 2024

Keywords: Epidemiology, Mortality, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Epidemiology & Public Health Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: This study aimed to analyze two decades of consecutive mortality data to investigate cardiovascular deaths in Systemic Lupus Erythematosus (SLE) across the United States (US), identifying patterns and disparities in mortality rates.

Methods: A retrospective analysis was conducted using mortality data from the CDC WONDER database spanning 1999-2020. ICD-10 codes (I00-I99) for diseases of the circulatory system and (M32) for SLE were used to identify cardiovascular-related deaths in SLE among adults aged 25 years and older at the time of death. Age-adjusted mortality rates (AAMRs) per 100,000 persons were calculated, and trends were assessed using Average Annual Percentage Change (AAPC) and Annual Percent Change (APC). Data were stratified by year, sex, race/ethnicity, and geographical regions.

Results: Between 1999 and 2020, cardiovascular-related deaths in SLE accounted for 6,548 deaths among adults aged 25 and older in the US. The overall AAMR for cardiovascular-related deaths in SLE decreased from 1.81 in 1999 to 1.53 in 2020, with an AAPC of -0.9963 (95% CI: -1.908 to 0.2433, p=0.025). A significant decline occurred from 1999 to 2014 (APC: -3.19; 95% CI: -5.56 to -2.17), followed by a notable increase from 2014 to 2020 (APC: 4.73; 95% CI: 0.407 to 18.29). Women exhibited higher AAMRs compared to men (women: 2.12, men: 0.53). The AAMR for both men and women decreased, with a steeper decline for men from 1999 to 2014 (APC: -4.85) compared to women in the same period (APC: -2.81). African Americans or Blacks had the highest AAMRs (3.54), followed by American Indians or Alaska Natives (1.6), Whites (1.12), and Asian/Pacific Islanders (1.02). The highest mortality was in the Western region (AAMR: 1.6). Geographically, AAMRs ranged from 0.62 in Massachusetts to 3.1 in Oklahoma. Metropolitan areas had higher AAMRs than non-metropolitan areas (1.41 vs. 1.29), with a significant decrease in non-metropolitan areas (AAPC: -1.0407, p=0.00639) and non-significant decrease in metropolitan areas (AAPC: -0.8617, p=0.1519).

Conclusion: This analysis highlights notable differences in mortality rates related to cardiovascular deaths in SLE. The target population was adult patients aged 25 and above in the United States. These results are based on demographic and geographic factors. Initially, there was a considerable decrease, but recently the mortality rates have started to rise. This underscores the importance of focused interventions to address disparities and improve health outcomes.

Supporting image 1

Supporting image 2


Disclosures: F. Ahmed: None; S. Patil: None; Y. Deshpande: None; S. Bhimani: None; A. Maligireddy: None; L. Hope: None; T. Mirza: None; M. Abugrin: None; H. Valand: None; C. Rojulpote: None; k. Gonuguntla: None.

To cite this abstract in AMA style:

Ahmed F, Patil S, Deshpande Y, Bhimani S, Maligireddy A, Hope L, Mirza T, Abugrin M, Valand H, Rojulpote C, Gonuguntla k. Trends and Disparities in Cardiovascular Deaths in Systemic Lupus Erythematosus: A Population-Based Retrospective Study in the United States from 1999 to 2021 [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/trends-and-disparities-in-cardiovascular-deaths-in-systemic-lupus-erythematosus-a-population-based-retrospective-study-in-the-united-states-from-1999-to-2021/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/trends-and-disparities-in-cardiovascular-deaths-in-systemic-lupus-erythematosus-a-population-based-retrospective-study-in-the-united-states-from-1999-to-2021/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology